SI-BONE Takes Cautious View for 2021 Despite Momentum

SI-BONE reported 2Q21 orthopedic revenue of $22.2 million, +58% vs. 2Q20. The company grew +36% compared to 2Q19. While SI-BONE performed solidly through the first half of 2021, it took a measured approach to the back half and restated its previous revenue guidance in the range of $92 million to $94 million, representing growth between +25%...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us